BIO Opposes H.R. 9, The Innovation Act

Jun 11 2015
BIO continues its continued opposition to The Innovation Act (H.R.9) as amended and reported by the House Judiciary Committee today.

BIO Releases Investment and Deal Making Study Showing Resurgence in Therapeutic Licensing

Jun 11 2015
BIO released a new report - Emerging Therapeutic Company Investment and Deal Trends – highlighting ten years (2005-2014) of biotechnology funding and deal making across five areas: venture capital, IPOs, follow-on public offerings, licensing, and acquisitions. The report also offers a first-time look at the degree of collaboration across the industry’s clinical pipeline.

BIO Statement on Senate Judiciary Committee Passage of PATENT Act

Jun 5 2015
BIO issued the following statement regarding the mark-up of The Protecting American Talent and Entrepreneurship (PATENT) Act

Key Leaders from Canadian R&D Scientists to Discuss Biomass Sustainability at 2015 BIO World Congress

Jun 4 2015


BIO Thanks USDA for Commitment to Building Renewable Fuel Infrastructure

Jun 1 2015
BIO  thanks Agriculture Secretary Tom Vilsack for making available grants to states that invest in expanding infrastructure for biofuels.

EPA’s Proposed RFS Rules Continue to Undercut Advanced Biofuels, BIO Says

May 29 2015
EPA has again proposed rules for the Renewable Fuel Standard that will continue to chill investment in the advanced biofuel sector and increase climate changing emissions.

BIO 2015 to Host an Evening Keynote with Wynton Marsalis

May 27 2015
Leading Jazz Musician to share his insights about the correlation between artists and entrepreneurs at the 2015 BIO International Convention

North Carolina Governor McCrory Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

May 22 2015
BIO & NCBIO commend Governor Pat McCrory for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines.

BIO Applauds Energy and Commerce Committee for Approving 21st Century Cures Act

May 21 2015
Biotechnology Industry Organization praises the Energy and Commerce Committee for approving the 21st Century Cures Act

BIO Applauds the U.S. House of Representatives for Passage of the American Research and Competitiveness Act

May 21 2015
By making this tax credit permanent, companies conducting their development programs will be able to estimate their tax liability and will not be burdened by the constant uncertainty regarding whether or not the R&D Tax Credit will be extended.